World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
67
Citations
16395
World Ranking
8205
National Ranking
3709

Andrew S. Kraft publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Andrew S. Kraft sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 214 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Andrew S. Kraft D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Andrew S. Kraft sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 67 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Andrew S. Kraft is affiliated with the University of Arizona in the United States. Their research spans multiple fields, primarily focusing on medicine and biochemistry, genetics, and molecular biology. Within these areas, Kraft's work delves into subfields such as pathology and forensic medicine, molecular biology, oncology, pulmonary and respiratory medicine, and public health, environmental, and occupational health.

The main research topics covered by Kraft include cancer mechanisms and therapy, acute lymphoblastic leukemia research, vascular tumors and angiosarcomas, RNA research and splicing, sarcoma diagnosis and treatment, lymphoma diagnosis and treatment, and chronic myeloid leukemia treatments.

Kraft has published in a variety of scientific venues. Frequent publication outlets include:

  • Cancer
  • Blood
  • Journal of Clinical Oncology
  • Nature Communications
  • EMBO Reports

Among recent papers authored or co-authored by Kraft are:

  • The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer, 2021, Nature Communications
  • EDC3 phosphorylation regulates growth and invasion through controlling P-body formation and dynamics, 2021, EMBO Reports
  • PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth, 2020, Molecular Oncology
  • An XBP1s-PIM-2 positive feedback loop controls IL-15-mediated survival of natural killer cells, 2023, Science Immunology
  • OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma, 2022, Cancer

Kraft frequently collaborates with several researchers. Common co-authors include Sathish K.R. Padi, Neha Singh, Kōichi Okumura, Jeremiah J. Bearss, and Ali McBride.

Best Publications

  • Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane.

    Andrew S. Kraft;Wayne B. Anderson

  • Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas

    Robert G. Maki;David R. D'Adamo;Mary L. Keohan;Michael Saulle

  • Conditional Expression of the Mitogen-activated Protein Kinase (MAPK) Phosphatase MKP-1 Preferentially Inhibits p38 MAPK and Stress-activated Protein Kinase in U937 Cells

    Christopher C. Franklin;Andrew S. Kraft

  • Decrease in cytosolic calcium/phospholipid-dependent protein kinase activity following phorbol ester treatment of EL4 thymoma cells.

    A S Kraft;W B Anderson;H L Cooper;J J Sando

  • The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter.

    Weiqing Zhang;Deborah E. Geiman;Janiel M. Shields;Duyen T. Dang

  • Elevated Akt Activity Protects the Prostate Cancer Cell Line LNCaP from TRAIL-induced Apoptosis

    Alexandre Nesterov;Xiaojun Lu;Michael Johnson;Gary J. Miller

  • The PIM-2 Kinase Phosphorylates BAD on Serine 112 and Reverses BAD-induced Cell Death

    Bin Yan;Marina Zemskova;Sheldon Holder;Vernon Chin

  • Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60

    Andrew S. Kraft;Jeffrey B. Smith;Roger L. Berkow

  • Bax-induced apoptotic cell death.

    John Pawlowski;Andrew S. Kraft

  • The 2014 Surgeon General's report: “The Health Consequences of Smoking–50 Years of Progress”: A paradigm shift in cancer care

    Graham W. Warren;Anthony J. Alberg;Andrew S. Kraft;K. Michael Cummings

  • The Role of the Transcription Factor Sp1 in Regulating the Expression of the WAF1/CIP1 Gene in U937 Leukemic Cells

    Joseph R. Biggs;Jeffery E. Kudlow;Andrew S. Kraft

  • Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor

    Stuart J. Frank;Stuart J. Frank;Woelsung Yi;Yanming Zhao;Jeffrey F. Goldsmith

  • The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells.

    Thomas R. Johnson;Kimberley Stone;Malti Nikrad;Tammie Yeh

  • The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim

    Malti Nikrad;Thomas Johnson;Thomas Johnson;Hamsa Puthalalath;Leigh Coultas

  • The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway.

    Michael Lilly;Jouko Sandholm;John J Cooper;Päivi J Koskinen

  • Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis

    Christopher C. Franklin;Sampathkumar Srikanth;Andrew S. Kraft

  • PIM kinase (and Akt) biology and signaling in tumors.

    Noel A. Warfel;Andrew S. Kraft

  • Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial

    Gary K. Schwartz;William D. Tap;Li Xuan Qin;Michael B. Livingston

  • The Amino-terminal Portion of the JAK2 Protein Kinase Is Necessary For Binding and Phosphorylation of the Granulocyte-Macrophage Colony-stimulating Factor Receptor β Chain ∗

    Yanming Zhao;Fred Wagner;Stuart J. Frank;Andrew S. Kraft

  • Pim family kinases enhance tumor growth of prostate cancer cells

    Wei Wei Chen;Daniel C. Chan;Carlton Donald;Michael B. Lilly

Frequent Co-Authors

Charles D. Smith
Charles D. Smith University of Kentucky
George R. Pettit
George R. Pettit Arizona State University
Xue-Zhong Yu
Xue-Zhong Yu Medical College of Wisconsin
Jon C. Aster
Jon C. Aster Harvard Medical School
Robert G. Maki
Robert G. Maki University of Pennsylvania
Peter D. Aplan
Peter D. Aplan National Institutes of Health
Stuart J. Frank
Stuart J. Frank University of Alabama at Birmingham
Dong-Er Zhang
Dong-Er Zhang University of California, San Diego
Anthony D. Elias
Anthony D. Elias University of Colorado Boulder
Cristina R. Antonescu
Cristina R. Antonescu Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Andrew S. Kraft

Trending Scientists

Recently Published Articles